Even if only the highly expressing HCA519/TPX2 + HCC cells are killed by activated CTLs, then the HCC tumor cell population as a whole might be sufficiently reduced, thereby hindering the in vivo tumor growth and in turn providing the patient with a longer survival. Here, TPX2 is linked to hepatocellular carcinoma.